|
1
|
McGuire WP, Hosk ins WJ, Brady MF, Kucera
PR, Partridge EE, Look KY, Clarke-Pearson DL and Davidson M:
Cyclophosphamide and cisplatin compared with paclitaxel and
cisplatin in patients with stage III and stage IV ovarian cancer. N
Engl J Med. 334:1–6. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Itamochi H, Kigawa J and Terakawa N:
Mechanisms of chemoresistance and poor prognosis in ovarian clear
cell carcinoma. Cancer Sci. 99:653–658. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Anglesio MS, Carey MS, Köbel M, Mackay H
and Huntsman DG; Vancouver Ovarian Clear Cell Symposium Speakers.
Clear cell carcinoma of the ovary: A report from the first Ovarian
Clear Cell Symposium, June 24th, 2010. Gynecol Oncol. 121:407–415.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Johnstone RW, Ruefli AA and Lowe SW:
Apoptosis: A link between cancer genetics and chemotherapy. Cell.
108:153–164. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cory S, Huang DCS and Adams JM: The Bcl-2
family: Roles in cell survival and oncogenesis. Oncogene.
22:8590–8607. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yip KW and Reed JC: Bcl-2 family proteins
and cancer. Oncogene. 27:6398–6406. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Czabotar PE, Lessene G, Strasser A and
Adams JM: Control of apoptosis by the BCL-2 protein family:
Implications for physiology and therapy. Nat Rev Mol Cell Biol.
15:49–63. 2014. View
Article : Google Scholar
|
|
9
|
Llambi F, Moldoveanu T, Tait SW,
Bouchier-Hayes L, Temirov J, McCormick LL, Dillon CP and Green DR:
A unified model of mammalian BCL-2 protein family interactions at
the mitochondria. Mol Cell. 44:517–531. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Oltersdorf T, Elmore SW, Shoemaker AR,
Armstrong RC, Augeri DJ, Belli BA, Bruncko M, Deckwerth TL, Dinges
J, Hajduk PJ, et al: An inhibitor of Bcl-2 family proteins induces
regression of solid tumours. Nature. 435:677–681. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
van Delft MF, Wei AH, Mason KD, Vandenberg
CJ, Chen L, Czabotar PE, Willis SN, Scott CL, Day CL, Cory S, et
al: The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and
efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized.
Cancer Cell. 10:389–399. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wertz IE, Kusam S, Lam C, Okamoto T,
Sandoval W, Anderson DJ, Helgason E, Ernst JA, Eby M, Liu J, et al:
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1
and FBW7. Nature. 471:110–114. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cohen NA, Stewart ML, Gavathiotis E,
Tepper JL, Bruekner SR, Koss B, Opferman JT and Walensky LD: A
competitive stapled peptide screen identifies a selective small
molecule that overcomes MCL-1-dependent leukemia cell survival.
Chem Biol. 19:1175–1186. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Takayama S, Xie Z and Reed JC: An
evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone
regulators. J Biol Chem. 274:781–786. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rosati A, Ammirante M, Gentilella A,
Basile A, Festa M, Pascale M, Marzullo L, Belisario MA, Tosco A,
Franceschelli S, et al: Apoptosis inhibition in cancer cells: A
novel molecular pathway that involves BAG3 protein. Int J Biochem
Cell Biol. 39:1337–1342. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Einbond A and Sudol M: Towards prediction
of cognate complexes between the WW domain and proline-rich
ligands. FEBS Lett. 384:1–8. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sudol M, Chen HI, Bougeret C, Einbond A
and Bork P: Characterization of a novel protein-binding module -
the WW domain. FEBS Lett. 369:67–71. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Iwasaki M, Homma S, Hishiya A, Dolezal SJ,
Reed JC and Takayama S: BAG3 regulates motility and adhesion of
epithelial cancer cells. Cancer Res. 67:10252–10259. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rosati A, Bersani S, Tavano F, Dalla Pozza
E, De Marco M, Palmieri M, De Laurenzi V, Franco R, Scognamiglio G,
Palaia R, et al: Expression of the antiapoptotic protein BAG3 is a
feature of pancreatic adenocarcinoma and its overexpression is
associated with poorer survival. Am J Pathol. 181:1524–1529. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Festa M, Del Valle L, Khalili K, Franco R,
Scognamiglio G, Graziano V, De Laurenzi V, Turco MC and Rosati A:
BAG3 protein is overexpressed in human glioblastoma and is a
potential target for therapy. Am J Pathol. 178:2504–2512. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chiappetta G, Basile A, Barbieri A, Falco
A, Rosati A, Festa M, Pasquinelli R, Califano D, Palma G, Costanzo
R, et al: The anti-apoptotic BAG3 protein is expressed in lung
carcinomas and regulates small cell lung carcinoma (SCLC) tumor
growth. Oncotarget. 5:6846–6853. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Boiani M, Daniel C, Liu X, Hogarty MD and
Marnett LJ: The stress protein BAG3 stabilizes Mcl-1 protein and
promotes survival of cancer cells and resistance to antagonist
ABT-737. J Biol Chem. 288:6980–6990. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jacobs AT and Marnett LJ: HSF1-mediated
BAG3 expression attenuates apoptosis in 4-hydroxynonenal-treated
colon cancer cells via stabilization of anti-apoptotic Bcl-2
proteins. J Biol Chem. 284:9176–9183. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schwickart M, Huang X, Lill JR, Liu J,
Ferrando R, French DM, Maecker H, O'Rourke K, Bazan F,
Eastham-Anderson J, et al: Deubiquitinase USP9X stabilizes MCL1 and
promotes tumour cell survival. Nature. 463:103–107. 2010.
View Article : Google Scholar
|
|
25
|
Yan J, Zhong N, Liu G, Chen K, Liu X, Su L
and Singhal S: Usp9x- and Noxa-mediated Mcl-1 downregulation
contributes to pemetrexed-induced apoptosis in human non-small-cell
lung cancer cells. Cell Death Dis. 5:e13162014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Suzuki M, Iwasaki M, Sugio A, Hishiya A,
Tanaka R, Endo T, Takayama S and Saito T: BAG3 (BCL2-associated
athanogene 3) interacts with MMP-2 to positively regulate invasion
by ovarian carcinoma cells. Cancer Lett. 303:65–71. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Homma S, Iwasaki M, Shelton GD, Engvall E,
Reed JC and Takayama S: BAG3 deficiency results in fulminant
myopathy and early lethality. Am J Pathol. 169:761–773. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sugio A, Iwasaki M, Habata S, Mariya T,
Suzuki M, Osogami H, Tamate M, Tanaka R and Saito T: BAG3
upregulates Mcl-1 through downregulation of miR-29b to induce
anticancer drug resistance in ovarian cancer. Gynecol Oncol.
134:615–623. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Konopleva M, Contractor R, Tsao T, Samudio
I, Ruvolo PP, Kitada S, Deng X, Zhai D, Shi YX, Sneed T, et al:
Mechanisms of apoptosis sensitivity and resistance to the BH3
mimetic ABT-737 in acute myeloid leukemia. Cancer Cell. 10:375–388.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tahir SK, Yang X, Anderson MG,
Morgan-Lappe SE, Sarthy AV, Chen J, Warner RB, Ng SC, Fesik SW,
Elmore SW, et al: Influence of Bcl-2 family members on the cellular
response of small-cell lung cancer cell lines to ABT-737. Cancer
Res. 67:1176–1183. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Glaser SP, Lee EF, Trounson E, Bouillet P,
Wei A, Fairlie WD, Izon DJ, Zuber J, Rappaport AR, Herold MJ, et
al: Mechanisms of chemoresistance and poor prognosis in ovarian
clear cell carcinoma. Genes Dev. 26:120–125. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xiang Z, Luo H, Payton JE, Cain J, Ley TJ,
Opferman JT and Tomasson MH: Mcl1 haploinsufficiency protects mice
from Myc-induced acute myeloid leukemia. J Clin Invest.
120:2109–2118. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wei G, Twomey D, Lamb J, Schlis K, Agarwal
J, Stam RW, Opferman JT, Sallan SE, den Boer ML, Pieters R, et al:
Gene expression-based chemical genomics identifies rapamycin as a
modulator of MCL1 and glucocorticoid resistance. Cancer Cell.
10:331–342. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wuillème-Toumi S, Robillard N, Gomez P,
Moreau P, Le Gouill S, Avet-Loiseau H, Harousseau JL, Amiot M and
Bataille R: Mcl-1 is overexpressed in multiple myeloma and
associated with relapse and shorter survival. Leukemia.
19:1248–1252. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhong Q, Gao W, Du F and Wang X:
Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the
polyubiquitination of Mcl-1 and regulates apoptosis. Cell.
121:1085–1095. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ding Q, He X, Hsu JM, Xia W, Chen CT, Li
LY, Lee DF, Liu JC, Zhong Q, Wang X, et al: Degradation of Mcl-1 by
beta-TrCP mediates glycogen synthase kinase 3-induced tumor
suppression and chemosensitization. Mol Cell Biol. 27:4006–4017.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Inuzuka H, Shaik S, Onoyama I, Gao D,
Tseng A, Maser RS, Zhai B, Wan L, Gutierrez A, Lau AW, et al:
SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for
ubiquitylation and destruction. Nature. 471:104–109. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Magiera MM, Mora S, Mojsa B, Robbins I,
Lassot I and Desagher S: Trim17-mediated ubiquitination and
degradation of Mcl-1 initiate apoptosis in neurons. Cell Death
Differ. 20:281–292. 2013. View Article : Google Scholar :
|
|
39
|
Aveic S, Pigazzi M and Basso G: BAG1: The
guardian of anti-apoptotic proteins in acute myeloid leukemia. PLoS
One. 6:e260972011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lüders J, Demand J and Höhfeld J: The
ubiquitin-related BAG-1 provides a link between the molecular
chaperones Hsc70/Hsp70 and the proteasome. J Biol Chem.
275:4613–4617. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Doong H, Rizzo K, Fang S, Kulpa V,
Weissman AM and Kohn EC: CAIR-1/BAG-3 abrogates heat shock
protein-70 chaperone complex-mediated protein degradation:
Accumulation of poly-ubiquitinated Hsp90 client proteins. J Biol
Chem. 278:28490–28500. 2003. View Article : Google Scholar : PubMed/NCBI
|
